OpenURL Connection Search

Select item for more details and to access through your institution.

A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 3, p. 776, doi. 10.1210/clinem/dgab731
By:
- Brose, Marcia S.;
- Panaseykin, Yury;
- Konda, Bhavana;
- de la Fouchardiere, Christelle;
- Hughes, Brett G. M.;
- Gianoukakis, Andrew G.;
- Young Joo Park;
- Romanov, Ilia;
- Krzyzanowska, Monika K.;
- Leboulleux, Sophie;
- Binder, Terri A.;
- Dutcus, Corina;
- Ran Xie;
- Taylor, Matthew H.
Publication type:
Article
Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer.
Published in:
2016
By:
- Robinson, Bruce;
- Schlumberger, Martin;
- Wirth, Lori J;
- Dutcus, Corina E;
- Song, James;
- Taylor, Matthew H;
- Kim, Sung-Bae;
- Krzyzanowska, Monika K;
- Capdevila, Jaume;
- Sherman, Steven I;
- Tahara, Makoto
Publication type:
journal article
Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib.
Published in:
Thyroid, 2021, v. 31, n. 8, p. 1226, doi. 10.1089/thy.2020.0779
By:
- Taylor, Matthew H.;
- Takahashi, Shunji;
- Capdevila, Jaume;
- Tahara, Makoto;
- Leboulleux, Sophie;
- Kiyota, Naomi;
- Dutcus, Corina E.;
- Xie, Ran;
- Robinson, Bruce;
- Sherman, Steven;
- Habra, Mouhammed Amir;
- Elisei, Rossella;
- Wirth, Lori J.
Publication type:
Article
Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.
Published in:
Thyroid, 2017, v. 27, n. 9, p. 1135, doi. 10.1089/thy.2016.0549
By:
- Naomi Kiyota;
- Robinson, Bruce;
- Manisha Shah;
- Hoff, Ana O.;
- Taylor, Matthew H.;
- Di Li;
- Dutcus, Corina E.;
- Eun Kyung Lee;
- Sung-Bae Kim;
- Makoto Tahara
Publication type:
Article
Lenvatinib for Anaplastic Thyrid Cancer.
Published in:
Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00025
By:
- Makoto Tahara;
- Naomi Kiyota;
- Tomoko Yamazaki;
- Naoko Chayahara;
- Kenji Nakano;
- Lina Inagaki;
- Kazuhisa Toda;
- Tomohiro Enokida;
- Hironobu Minami;
- Yoshinori Imamura;
- Tatsuya Sasaki;
- Takuya Suzuki;
- Katsuki Fujino;
- Dutcus, Corina E.;
- Shunji Takahashi
Publication type:
Article
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer.
Published in:
Breast Cancer: Basic & Clinical Research, 2016, n. 10, p. 77, doi. 10.4137/BCBCr.s39615
By:
- Twelves, Chris;
- Awada, Ahmad;
- Cortes, Javier;
- Yelle, Louise;
- Velikova, Galina;
- Olivo, Martin S.;
- Song, James;
- Dutcus, Corina E.;
- Kaufman, Peter A.
Publication type:
Article
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
Published in:
2019
By:
- Evans, Thomas R. Jeffry;
- Kudo, Masatoshi;
- Finn, Richard S.;
- Han, Kwang-Hyub;
- Cheng, Ann-Lii;
- Ikeda, Masafumi;
- Kraljevic, Silvija;
- Ren, Min;
- Dutcus, Corina E.;
- Piscaglia, Fabio;
- Sung, Max W.
Publication type:
corrected article
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
Published in:
2019
By:
- Evans, Thomas R. Jeffry;
- Kudo, Masatoshi;
- Finn, Richard S.;
- Han, Kwang-Hyub;
- Cheng, Ann-Lii;
- Ikeda, Masafumi;
- Kraljevic, Silvija;
- Ren, Min;
- Dutcus, Corina E.;
- Piscaglia, Fabio;
- Sung, Max W.
Publication type:
journal article
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study.
Published in:
2018
By:
- Tibes, Raoul;
- Borad, Mitesh J.;
- Dutcus, Corina E.;
- Reyderman, Larisa;
- Feit, Kevie;
- Eisen, Andrew;
- Verbel, David A.;
- Von Hoff, Daniel D.
Publication type:
journal article
Exposure-response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer.
Published in:
2018
By:
- Hayato, Seiichi;
- Shumaker, Robert;
- Ferry, Jim;
- Binder, Terri;
- Dutcus, Corina E.;
- Hussein, Ziad
Publication type:
journal article
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma.
Published in:
2021
By:
- Lee, Chung-Han;
- Motzer, Robert J.;
- Glen, Hilary;
- Michaelson, M. D.;
- Larkin, James;
- Minoshima, Yukinori;
- Kanekiyo, Michio;
- Ikezawa, Hiroki;
- Sachdev, Pallavi;
- Dutcus, Corina E.;
- Funahashi, Yasuhiro;
- Voss, Martin H.
Publication type:
journal article
Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes.
Published in:
Endocrine (1355008X), 2017, v. 56, n. 1, p. 121, doi. 10.1007/s12020-017-1233-5
By:
- Haddad, Robert;
- Schlumberger, Martin;
- Wirth, Lori;
- Sherman, Eric;
- Shah, Manisha;
- Robinson, Bruce;
- Dutcus, Corina;
- Teng, Angela;
- Gianoukakis, Andrew;
- Sherman, Steven
Publication type:
Article
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.
Published in:
2021
By:
- Okusaka, Takuji;
- Ikeda, Kenji;
- Kudo, Masatoshi;
- Finn, Richard;
- Qin, Shukui;
- Han, Kwang-Hyub;
- Cheng, Ann-Lii;
- Piscaglia, Fabio;
- Kobayashi, Masahiro;
- Sung, Max;
- Chen, Minshan;
- Wyrwicz, Lucjan;
- Yoon, Jung-Hwan;
- Ren, Zhenggang;
- Mody, Kalgi;
- Dutcus, Corina;
- Tamai, Toshiyuki;
- Ren, Min;
- Hayato, Seiichi;
- Kumada, Hiromitsu
Publication type:
journal article
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
Published in:
2018
By:
- Wirth, Lori J.;
- Tahara, Makoto;
- Robinson, Bruce;
- Francis, Sanjeev;
- Brose, Marcia S.;
- Habra, Mouhammed Amir;
- Newbold, Kate;
- Kiyota, Naomi;
- Dutcus, Corina E.;
- Mathias, Elton;
- Guo, Matthew;
- Sherman, Steven I.;
- Schlumberger, Martin
Publication type:
journal article
Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer.
Published in:
Oncologist, 2014, v. 19, n. 4, p. 318, doi. 10.1634/theoncologist.2013-0282
By:
- Muss, Hyman;
- Cortes, Javier;
- Vahdat, Linda T.;
- Cardoso, Fatima;
- Twelves, Chris;
- Wanders, Jantien;
- Dutcus, Corina E.;
- Yang, Jay;
- Seegobin, Seth;
- O'Shaughnessy, Joyce
Publication type:
Article
Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple‐negative breast cancer: Results from the triple‐negative breast cancer cohort of the phase 2 LEAP‐005 Study.
Published in:
Cancer (0008543X), 2024, v. 130, n. 19, p. 3278, doi. 10.1002/cncr.35387
By:
- Chung, Hyun Cheol;
- Saada‐Bouzid, Esma;
- Longo, Federico;
- Yanez, Eduardo;
- Im, Seock‐Ah;
- Castanon, Eduardo;
- Desautels, Danielle N.;
- Graham, Donna M.;
- Garcia‐Corbacho, Javier;
- Lopez, Juanita;
- Dutcus, Corina;
- Okpara, Chinyere E.;
- Ghori, Razi;
- Jin, Fan;
- Groisberg, Roman;
- Korakis, Iphigenie
Publication type:
Article

Found: 16